33° Congresso Nazionale
della Società Italiana di Farmacologia

Cagliari, 6-9 Giugno 2007
Fiera della Sardegna

 

 

DATABASE

ABSTRACTS 501-600

 



ELENCO ABSTRACTS 501-600

 

Elenco globale contributi
501-600

 

Cod
1° Autore
Titolo (prime parole)
Status
501
Ercolano
Emanuela
TRANSPORT OF PYRIDINE NUCLEOTIDES ACROSS THE PLASMA...
OK
502
Fiorentini
Anna
IN VIVO CHARACTERIZATION OF DKK-1 EXPRESSION IN...
OK
503
Mognetti
Barbara
PRECLINICAL EVALUATION OF A NEW THERAPEUTIC APPROACH...
OK
504
Gnemmi
Ilaria
HDAC INHIBITORS RESTORE THE p53 PATHWAY IN...
OK
505
Carmignani
Marco
HUMAN UMBILICAL CORD-DERIVED HEMATOPOIETIC STEM...
OK
506
Carmignani
Marco
CRITICAL SPLANCHNIC ARTERY HYPOPERFUSION CAUSES...
OK
507
Volpe
Anna
LOW-LEVEL LEAD, CADMIUM AND VANADIUM: “IN VITRO”...
OK
508
Hoozemans
Jeroen
INVESTIGATION OF WNT SIGNALING FACTORS IN POSTMORTEM...
OK
509
Bucci
Mariarosaria
TESTOSTERONE-INDUCED VASORELAXATION INVOLVES L-...
OK
510
Roviezzo
Fiorentina
SPHINGOSINE-1-PHOSPHATE/SPHINGOSINE KINASE PATHWAY...
OK
511
Vellecco
Valentina
INHIBITORS OF CYSTATHIONINE-?-LYASE (CSE), PROPARGYLGLYCINE...
OK
512
Bombelli
Raffaella
ANTIOXIDANT PROPERTIES OF INFUSIONS FROM LEAVES...
OK
513
Angelini
Sabrina
GENETIC POLYMORPHISMS IN DNA REPAIR GENES AND THEIR...
OK
514
Scali
Carla
DISCOVERY OF A SERIES OF MOLECULES ACTING AS POTENT...
OK
515
Gelosa
Paolo
GPR17: A NEW DUAL RECEPTOR FOR BOTH EXTRACELLULAR...
OK
516
Gianella
Anita
ROSUVASTATIN PREVENTS PROGRESSIVE KIDNEY INFLAMMATION...
OK
517
Savani
Claudia
EVIDENCE FOR PEA ANTIINFLAMMATORY PROPERTIES IN...
OK
518
Solito
Raffaella
PGE2 PROMOTES EGFR TRANSACTIVATION AND SQUAMOUS...
OK
519
Solito
Raffaella
THE BH4 DOMAIN OF BCL-XL COUNTERACTS BETA AMYLOID...
OK
520
Esposito
Giuseppe
S100B PROTEIN PROMOTES TAU PROTEIN HYPERPHOSPHO...
OK
521
Alacqua
Marianna
ANTICOAGULANTS AND DRUGS AT INTERACTION RISK...
OK
522
Scuderi
Caterina
CANNABIDIOL IN VIVO SUPPRESSES Aß INDUCED REACTIVE...
OK
523
Betti
Niccolò
PKCd ISOENZYME IS INVOLVED IN GROWTH AND ANGIOGENESIS...
OK
524
Cantoni
Orazio
THE IDENTIFICATION OF MOLECULAR MECHANISMS...
OK
525
Grossi
Cristina
IN VIVO EFFECT OF CLIOQUINOL TREATMENT IN A MOUSE...
OK
526
Colangelo
Donato
TEMPERATURE INFLUENCE ON CELLULAR UPTAKE, DNA...
OK
527
Biagioni
Francesca
INDUCTION OF THE WNT INHIBITOR, DICKKOPF-1, IS ASSOCIATED...
OK
528
Bruno
Valeria
INDUCTION OF THE WNT ANTAGONIST, DICKKOPF-1, AS A...
OK
529
Busceti
Carla
3,4-METHYLENDIOXYMETHAMPHETAMINE (ECSTASY) INDUCES...
OK
530
Molinaro
Gemma
GABAERGIC DRUGS BECOME NEUROTOXIC IN CORTICAL NEURONS...
OK

531

Santolini
Ines
SELECTIVE ACTIVATION OF METABOTROPIC GLUTAMATE...
OK
532
Orlando
Rosamaria
NANOMOLAR CONCENTRATIONS OF ANABOLIC-ANDROGENIC...
OK
533
Luccini
Elisa
MECHANISMS OF [3H]GLYCINE RELEASE FROM MOUSE...
OK
534
Luppino
MariaRosa
INDIPENDENT DRUG INFORMATION AND PRESCIBING...
OK
535
Froldi
Guglielmina
DIRECT EFFECTS OF TICLOPIDINE AND CLOPIDOGREL ON...
OK
536
Maffei
Francesca
GENETIC POLYMORPHISM OF BLEOMYCIN HYDROLASE:...
OK
537
Botti
Francesca
ADULT NEURAL STEM CELLS (ANSCs) AS A TOOL TO STUDY...
OK
538
Gatta
Luisa
2-CHLORO-2’-C-METHYL-N6-CYCLOPENTYLADENOSINE,...
OK
539
Curatolo
Paolo
QUALITY OF LIFE OF PEDIATRIC PATIENTS WITH ATTENTION...
OK
540
Kelsey
Douglas
EVENING AND EARLY MORNING ADMINISTRATION OF...
OK
541
Heine
Robert J
EXENATIDE ACHIEVED EQUIVALENT GLYCEMIC CONTROL...
OK
542
Nauck
Michael
EFFECTS OF EXENATIDE COMPARED WITH TWICE-DAILY
OK
543
Barnett
Anthony
A COMPARISON OF EXENATIDE AND INSULIN GLARGINE IN...
OK
544
Zinman
Bernard
SAFETY AND EFFICACY OF EXENATIDE OVER 16 WEEKS IN...
OK
545
Fusco
Ferdinando
SILDENAFIL CITRARE VERSUS TADALAFIL FOR ED...
OK
546
Barraco
Alessandra
SAFETY AND TOLERABILITY OF DULOXETINE IN THE TREATMENT...
OK
547
Mancini
Michele
THE NEW ANTIDEPRESSANT DULOXETINE: CARDIOVASCULAR...
OK
548
Bellantuono
Cesario
THE MANAGEMENT OF BIPOLAR MANIA: A NATIONAL SURVEY...
OK
549
Rossi
Andrea
EUROPEAN MANIA IN BIPOLAR LONGITUDINAL EVALUATION...
OK
550
Brausi
Maurizio
PHASE II MARKER LESION STUDY OF 6-WEEK INTRAVESICAL...
OK
551
Novick
Diego
EFFECTIVENESS OF ANTIPSYCHOTIC TREATMENT IN OUTPATIENTS...
OK
552
Novick
Diego
TOLERABILITY OF OUTPATIENT ANTIPSYCHOTIC TREATMENT...
OK
553
Dellabianca
Antonio
MODULATION OF THE NON-ADRENERGIC, NON-CHOLINERGIC...
OK
554
Nizzari
Mario
AMYLOID PRECURSOR PROTEIN AND PRESENILIN1 INTERACT...
OK
555
Marcoli
Manuela
cGMP CONTROL OF KAINATE RECEPTOR ACTIVATION IN...
OK
556
Scorziello
Antonella
ANOXIC PRECONDITIONING-INDUCED NEUROPROTECTION...
OK
557
Guida
Francesca
2-CHLORO-2’-C-METHYL-N6-CYCLOPENTYLADENOSINE...
OK
558
Ferraro
Luca
NEUROTENSIN RECEPTOR INVOLVEMENT IN THE RISE...
OK
559
Reitano
Erika
BEHAVIOUR OF EGFP-LABELLED NS CELLS TRANSPLANTED...
OK
560
Alloisio
Susanna
EXTRACELLULAR MG2+ MODULATES C-TERMINAL TAIL...
OK
561
Russo
Rossella
DEFINITION OF A ROLE FOR MATRIX METALLOPROTEINASES...
OK
562
Anzellotti
Paola
NCX-4040, A NITRIC OXIDE-DONATING ASPIRIN DERIVATIVE ...
OK
563
Capone
Marta L
HUMAN PHARMACOLOGY OF NAPROXEN SODIUM
OK
564
Di Francesco
Luigia
DIFFERENTIAL CONTRIBUTION OF CYCLOOOXYGENASE-...
OK
565
Tacconelli
Stefania
HUMAN PROSTACYCLIN RECEPTOR POLYMORPHISMS AND...
OK
566
Bolego
Chiara
ESTROGEN RECEPTOR-ALPHA IS INVOLVED IN THE REGULATION...
OK
567
Crea
Francesco
EPIGENETIC MECHANISMS OF SENSITIVITY TO IRINOTECAN...
OK
568
Milanese
Marco
Glutamate release induced by activation of GAT-1...
OK
569
Invernizzi
Roberto W
ROLE OF TRYPTOPHAN HYDROXYLASE-2 IN THE RESPONSE...
OK
570
Fantozzi
Roberto
“The pharmacist and therapeutic emergencies”
OK
571
Campioli
Enrico
ENDOGENOUS BENZODIAZEPINES AND INTESTINAL BACTERIAL...
OK
572
Zappettini
Simona
ADULT ASTROGLIA IS COMPETENT FOR NA+/CA2+ EXCHANGER...
OK
573
Bianco
Giuseppe
ANGIOTENSIN II INVOLVEMENT IN REMODELLING OF...
OK
574
Cacciapaglia
Fabio
RECIPROCAL EFFECTS OF RESPONSE CONTINGENT AND NON...
OK
575
Bonatesta
Rosa Rita
PEGYLATION OF RECOMBINANT HUMAN GRANULOCYTE...
OK
576
Caboi
Francesca
PROLONGING THE ACTION OF RECOMBINANT HUMAN...
OK
577
Loraschi
Anna
ATORVASTATIN TREATMENT INFLUENCES POLYMORPHO...
OK
578

Maio

Ramona C

TREATMENT WITH SIMVASTATIN MODIFIES AT1R EXPRESSION...
OK
579
Schembri
Laura
EFFECTS OF ATORVASTATIN TREATMENT ON THE MODULATION...
OK
580

Tarozzi

Andrea

SULFORAPHANE INHIBITS 6-HYDROXYDOPAMINE-INDUCED...
OK
581
Simola
Nicola
ROLE OF DOPAMINE D1 RECEPTOR IN MORPHINE- AND...
OK
582
Simola
Nicola
BLOCKADE OF PALLIDAL ADENOSINE A2A RECEPTORS...
OK
583

Fedeli

Amalia

CENTRAL ADMINISTRATION OF NEUROPEPTIDE S (NPS)...
OK
584
Pillolla
Giuliano
MEDIAL FOREBRAIN BUNDLE STIMULATION INDUCES SHORT...
OK
585
Pegoraro
Paola
THE MAGNITUDE OF INHIBITORY DRUG INTERACTIONS IS...
OK
586
Losi
Gabriele
DIRECT MODULATION OF GABAERGIC TRANSMISSION...
OK
587
Salis
Barbara
NOVEL G-CSF MUTANT FOR CONJUGATION...
OK
588
Selis
Fabio
NEW LONG LASTING PEGylated-hGH
OK
589
Sergi
Mauro
SILICA MICROPARTICLES FOR THE CONTROLLED RELEASE...
OK
590

Del Vecchio

Igor

MAPPING OF THE HUMAN PROMOTER OF GNB2L1 GENE ENCODING...
OK
591
Garzon
Giorgio
IMPORTANCE OF PROTEIN KINASE C EPSILON ?FOR THE...
OK
592
Lograno
Marcello
BIOCHEMICAL AND PHARMACOLOGICAL EVIDENCES FOR...
OK
593
Maullu
Carlo
PRODUCTION OF INTERFERON-? (IFN- ?) IN E. COLI AND...
OK
594
Fimognari
Carmela
SIGNALING PATHWAYS AND INTRACELLULAR TARGETS...
OK
595

Stopponi

Serena

REDUCTION OF ETHANOL DRINKING FOLLOWING CHRONIC...
OK
596
Polimeni
Giovanni
PROVIDING RELIABLE PHARMACOVIGILANCE INFORMATION...
OK
597
Camera
Marina
CHARACTERIZATION OF TISSUE FACTOR EXPRESSION IN...
OK
598

Brambilla

Marta

EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES...
OK
599

Marino

Franca

DOPAMINERGIC MODULATION OF REGULATORY T LYMPHOCYTES...
OK
600

Domenici

Maria Rosaria

EVIDENCE FOR A POSSIBLE INTERACTION BETWEEN...
OK

 

 

Elenco globale contributi
501-600

 


 

 

 



Webmaster: Federico Casale - Ultimo aggiornamento: 08 Maggio 2007